Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Bacterial vaginosis is the most frequent condition associated to the vaginal microbiota imbalance, affecting about the 40–50% of women in the world. Even if antibiotics are effcetive for bacterial vaginosis treatment a long-term recurrence rates, higher than 70%, is recorded. Lactoferrin is an iron-binding glycoprotein with bacteriostatic and bactericidal properties. It owns the ability to protect the host against infection, by binding and regulating the iron needed for the bacterial proliferation.Objective: The present study was an open prospective randomized trial (registration no. SHI-EVE-2014.01) aimed at characterizing the bacterial biota of women affected by bacterial vaginosis (BV) and assessing the effects of two different lactoferrin concentrations (100 mg and 200 mg vaginal pessaries) on the composition and dynamics of the vaginal bacterial biota.Design: Sixty women with BV were recruited and randomized into two groups to receive lactoferrin pessaries for 10 days. Clinical evaluation was based on Amsel criteria and Nugent scores. Culture-dependent methods and Ion Torrent PGM sequencing of the 16S rRNA gene were applied to study in depth the overall structure of the vaginal bacterial biota and its dynamics during the treatment.Results: Vaginal lactoferrin administration modified the vaginal microbiota composition in patients with BV. During treatment, both 100 mg and 200 mg lactoferrin vaginal pessaries significantly decreased the occurrence of bacteria associated with BV, such as Gardnerella, Prevotella, and Lachnospira, and increased the occurrence of Lactobacillus species. The bacterial biota balance was maintained up to 2 weeks after treatment only in women treated with 200 mg lactoferrin pessaries.Conclusions: This study indicates that lactoferrin could be proposed as an alternative therapeutic approach for BV. Our data showed, for the first time, the dominance of Lactobacillus helveticus species during and after vaginal lactoferrin treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quail, M., Smith, M. E., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., Bertoni, A., Swerdlow, H. P., & Gu, Y. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-341 · Cited by 2,031 · cited 1×
“method with a faster turnaround than other nextgeneration sequencing techniques [43,44].”
MethodMolecular Identification of Bacteria Associated with Bacterial Vaginosis
Fredricks, D. N., Fiedler, T. L., & Marrazzo, J. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043802 · Cited by 1,303 · cited 1×
“urealyticum, and Mycoplasma hominis [1,14,15].”
Albers, S.-V., & Meyer, B. H. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2576 · Cited by 542
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523 · cited 1×
“It is noteworthy that vaginal Lactobacillus species can create a barrier against invasion by pathogens, since the products of their metabolism secreted in the cervicovaginal fluid play an important role in the inhibition of bacterial and viral infections [48].”
BackgroundRegulation of cytokine release from mononuclear cells by the iron- binding protein lactoferrin
Crouch, S., Slater, K., & Fletcher, J. (1992) · Blood · doi:10.1182/blood.v80.1.235.235 · Cited by 294
Current Treatment of Bacterial Vaginosis—Limitations and Need for Innovation
Bradshaw, C. S., & Sobel, J. D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw159 · Cited by 245
Cited by
Detection of Vaginal Lactobacilli as Probiotic Candidates
Pino, A., Bartolo, E., Caggia, C., Cianci, A., & Randazzo, C. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-40304-3 · Cited by 131
Self-citationRusso, R., Superti, F., Karadja, E., & De Seta, F. (2019) · Mycoses · doi:10.1111/myc.12883 · Cited by 94
Joseph, R. J., Ser, H.-L., Kuai, Y.-H., Tan, L. T.-H., Arasoo, V. J. T., Letchumanan, V., Wang, L., Pusparajah, P., Goh, B.-H., Ab Mutalib, N.-S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10060719 · Cited by 68
Metadata
- Authors
- Pino, A., Giunta, G., Randazzo, C. L., Caruso, S., Caggia, C., & Cianci, A.
- Venue
- Microbial Ecology in Health and Disease
- Publisher
- Informa UK Limited
- Published
- 2017-01
- Volume
- 28
- Issue
- 1
- Pages
- 1357417-1357417
- ISSN
- 0891-060X (ISSN-L)
- 1651-2235
- OpenAlex
- W2743947507
- Cited by
- 48
- References
- 6
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. https://app.cochat.ai/papers/10.1080/16512235.2017.1357417
- The paper
- Pino, A., Giunta, G., Randazzo, C. L., Caruso, S., Caggia, C., & Cianci, A. (2017). Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microbial Ecology in Health and Disease. https://doi.org/10.1080/16512235.2017.1357417
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.